Abstract
The present study was undertaken to determine the prevalence of hepatitis C virus (HCV) infection by antibody testing in hemodialysis (HD) patients. A total of 102 chronic renal failure patients on HD was studied. All the patients were tested for antiHCV. The overall prevalence of HCV infection was 23.5%. The longer a patient is on HD, the more susceptible he/she is to HCV acquisition. It is recommended that HD patients should be monitored in order to determine the full risk factors for HCV contamination observed in this study.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
